OACCU Oaktree Acquisition Corp. III Life Sciences - Unit

NAS · US · Financial Services · Shell Companies · oaktreeacquisitioncorp.com

11.00USD0.00%Mkt Cap: —P/E: —6d ago

Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combinat…

Industry Peers

Shell Companies

Armada Acquisition Corp. II

$790.07MUSDP/E 227.4

DMII

Drugs Made In America Acquisition II Corp.

$649.10MUSDP/E 34.0

CCXI

Churchill Capital Corp XI

$626.07MUSD

EVAC

EQV Ventures Acquisition Corp. II

$602.60MUSDP/E 34.4

BCSS

Bain Capital GSS Investment Cor

$596.85MUSD

CXII

Churchill Capital Corp XII

$591.61MUSD

CEPF

Cantor Equity Partners IV, Inc.

$586.93MUSDP/E 31.1

AC8

Intuitive Investments Group Plc

$532.06MUSDP/E 2.5

AEXA

American Exceptionalism Acquisition Corp. A

$536.65MUSD

NWAX

New America Acquisition I Corp.

$500.24MUSD

AAC

Ares Acquisition Corporation III

$496.66MUSD

MLAA

Mountain Lake Acquisition Corp. II

$490.34MUSD

KRSP

Rice Acquisition Corporation 3

$486.71MUSD

BRTM

B&R Technology Merger Corp.

$478.69MUSD

CRAN

Crane Harbor Acquisition Corp. II

$473.69MUSD

GTEN

Gores Holdings X, Inc.

$470.58MUSDP/E 21.3

GCGR

General Catalyst Global Resilience Merger Corp.

$467.87MUSD

APXT

Apex Treasury Corporation

$466.49MUSD

BCCQ

Bleichroeder Acquisition Corp. III

$457.24MUSD

Key Statistics

Company

Market Cap—

Enterprise Value269.21M USD

Revenue (TTM)—

Gross Profit—

Net Income (TTM)7.29M USD

Revenue/Share—

Last Price11.00 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees—

CountryUS

SectorFinancial Services

IndustryShell Companies

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA—

EV/Revenue—

P/S—

P/B-36.06

EPS (TTM)—

EPS (Forward)—

52W Range

10.6420% of range12.47

52W High12.47 USD

52W Low10.64 USD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE3.74%

ROA3.59%

Growth

Revenue Growth—

Earnings Growth-14.40%

Cash Flow & Leverage

Operating CF-422.08K USD

CapEx (TTM)—

FCF Margin—

FCF Yield—

Net Debt-1.17M USD

Net Debt/EBITDA—

Balance Sheet

Debt/Equity0.00

Current Ratio0.73

Quick Ratio0.68

Book Value/Sh-0.30 USD

Cash/Share0.05 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 USD

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.—

Float18.46M

Insiders3.04%

Institutions4.53%

Short Interest

Short Ratio48.3d

Shares Short1.95K

Short (prev mo.)1.98K

Technical

SMA 5010.99 (+0.1%)

SMA 20010.80 (+1.9%)

Beta—

S&P 52W Chg15.78%

Avg Vol (30d)0

Avg Vol (10d)0

Technical Indicators

RSI (14)79.2

MACD0.0054

MACD Signal0.0078

MACD Hist.-0.0024

BB Upper11.00 USD

BB Middle11.00 USD

BB Lower11.00 USD

BB Width0.00%

ATR (14)0.0010 USD

Vol Ratio (20d)—